Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fludrocortisone acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Hormonal Therapy with Tamoxifen vs Aminoglutethimide and Dexamethasone vs Adrenalectomy for Metastatic Breast Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2176
Phase II Mitotane plus Cortisone Acetate/Fludrocortisone and ADR for Residual, Recurrent, or Metastatic Adrenal Cortical Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: EST-1879
Phase II Chemotherapy with Mitotane/CACP for Metastatic or Residual Unresectable Adrenal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8325, SEG-INT-GU-217
Phase II Hormone Therapy with Aminoglutethimide in Patients with Relapsed Stage III/IV Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-7284
Phase II Randomized Second-Line Endocrine Therapy with AG/HC vs AG vs Low-Dose AG vs Low-Dose AG/HC vs HC in Patients with Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: EORTC-10861
Phase I Study of SUR in Patients with Advanced Cancer (Summary Last Modified 11/98)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-6274, NCI-T91-0212C, T91-0212
Orchiectomy with or without Subsequent Adrenalectomy for Metastatic Cancer of the Male Breast and Adjuvant Therapy for Stage II Male Breast Cancer
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-76-C-198, NCI-MB-82, NCI-T83-1248N, T83-1248
Start Over